Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study / J, Trujillo-Santos; D, Farge-Bancel; Jm, Pedrajas; C, Gómez-Cuervo; A, Ballaz; A, Braester; I, Mahé; A, Villalobos; Ja, Porras; M, Monreal; Investigators, Riete; D Adarraga, M; Aibar, J; A Aibar, M; Amado, C; I Arcelus, J; Asuero, A; Barba, R; Barbagelata, C; Barrón, M; Barrón-Andrés, B; Blanco-Molina, A; Botella, E; M Camon, A; Casado, I; Castro, J; Castro, M; Chasco, L; Criado, J; de Ancos, C; Del Toro, J; Demelo-Rodríguez, P; M Díaz-Brasero, A; A Díaz-Peromingo, J; V Di Campli, M; Dubois-Silva, A; C Escribano, J; Espósito, F; Falgá, C; I Farfán-Sedano, A; Fernández-Capitán, C; L Fernández-Reyes, J; A Fidalgo, M; Flores, K; Font, C; Font, L; Francisco, I; Gabara, C; Galeano-Valle, F; A García, M; García-Bragado, F; García de Herreros, M; García de la Garza, R; García-Díaz, C; García-Hernáez, R; García-Raso, A; Gil-Díaz, A; Giménez-Suau, M; Grau, E; Guirado, L; Gutiérrez, J; Hernández-Blasco, L; Hernando, E; Jara-Palomares, L; J Jaras, M; Jiménez, D; Jiménez, R; Jiménez-Alfaro, C; D Joya, M; Lainez-Justo, S; Latorre, A; Lima, J; Llamas, P; L Lobo, J; López-Jiménez, L; López-Miguel, P; J López-Núñez, J; López-Reyes, R; B López-Sáez, J; Lorenzo, A; Madridano, O; Maestre, A; J Marchena, P; Martín-Martos, F; Martínez-Urbistondo, D; Mella, C; I Mercado, M; Moisés, J; V Morales, M; Muñoz-Blanco, A; Muñoz-Rivas, N; S Navas, M; A Nieto, J; Nofuentes-Pérez, E; J Núñez-Fernández, M; Obispo, B; Olid, M; C Olivares, M; L Orcastegui, J; Osorio, J; Otalora, S; Otero, R; Paredes, D; Parra, P; Pellejero, G; Portillo, J; Rivera-Civico, F; A Rodríguez-Chiaradía, D; Rodríguez-Matute, C; Rogado, J; Rosa, V; Ruiz-Artacho, P; Ruiz-Giménez, N; Ruiz-Ruiz, J; Ruiz-Sada, P; Salgueiro, G; Sánchez-Martínez, R; F Sánchez-Muñoz-Torrero, J; Sancho, T; Soler, S; Suárez-Rodríguez, B; M Suriñach, J; Tirado, R; I Torres, M; Tolosa, C; Uresandi, F; Valero, B; Valle, R; F Varona, J; Vidal, G; Villares, P; Zamora, C; Engelen, M; Vanassche, T; Verhamme, P; Hirmerova, J; Malý, R; Ait Abdallah, N; Bertoletti, L; Bura-Riviere, A; Catella, J; Couturaud, F; Crichi, B; Debourdeau, P; Espitia, O; Falvo, N; Helfer, H; Lacut, K; Le Mao, R; Moustafa, F; Poenou, G; Quere, I; Schellong, S; Brenner, B; Tzoran, I; Nikandish, R; Bilora, F; Brandolin, B; Ciammaichella, M; Di Micco, P; Imbalzano, E; Maida, R; Pace, F; Pesavento, R; Prandoni, P; Quintavalla, R; Rocci, A; Siniscalchi, C; Tufano, A; Visonà, A; Zalunardo, B; Birzulis, J; Skride, A; Zaicenko, A; Fonseca, S; Martins, F; Meireles, J; Bosevski, M; Bounameaux, H; Mazzolai, L; I Ochoa-Chaar, C; Weinberg, I; M Bui, H. - In: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. - ISSN 2475-0379. - (2022). [10.1002/rth2.12736]
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
A TufanoInvestigation
;
2022
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
